Metraipolis › archive › dc_79708c83cf67

Efficacy of Bioengineered PD-L1 siRNA for Immunotherapy Against Non-Small Cell Lung Cancer Cells — Europe PMC PMID:42646357

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42646357
DOI
10.3390/ncrna12040026
License (as archived)
solo-consultazione
Archived
2026-10-17T15:17:20.972Z
SHA-256 of the archived text
4ecbba2e2470cb749e46a0bcf7a9ae89577ed104756e4bf63a50095c3a26198d
Stable URL of this page
https://metraipolis.com/documento/dc_79708c83cf67

How to cite

Efficacy of Bioengineered PD-L1 siRNA for Immunotherapy Against Non-Small Cell Lung Cancer Cells — Europe PMC PMID:42646357 — Europe PMC (en), https://europepmc.org/article/MED/42646357 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_79708c83cf67 (Metraipolis archive dc_79708c83cf67, sha256 4ecbba2e2470cb749e46a0bcf7a9ae89577ed104756e4bf63a50095c3a26198d)
BibTeX
@misc{dc79708c83cf67,
  title = {Efficacy of Bioengineered PD-L1 siRNA for Immunotherapy Against Non-Small Cell Lung Cancer Cells — Europe PMC PMID:42646357},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42646357},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_79708c83cf67; sha256 4ecbba2e2470cb749e46a0bcf7a9ae89577ed104756e4bf63a50095c3a26198d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42646357. Agents can read the archived copy with the MCP tool read_document.